DrugsControl Media Services

News Detail

Qiagen receives CDSCO approval for NeuMoDx HIV-1, HBV and HCV quant assays (01-11-2023)

Mumbai, 31 Oct 2023: Qiagen, a Netherlands-based holding company, announced that its NeuMoDx human immunodeficiency virus type 1 (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV) quantitative assays for blood-borne virus (BBV) testing has received Central Drugs Standar......
View Details

Source : Pharmabiz
Qiagen NeuMoDx human immunodeficiency virus HIV-1 hepatitis B virus HBV HCV blood-borne virus BBV CDSCO CE-IVD tests

Related News